Exploring circulating biomarkers for risk prediction of incident atrial fibrillation – insights from the BiomarCaRE project
Betül Toprak(Universität Hamburg), R B Schnabel(Universität Hamburg), Wolfgang Köenig(German Centre for Cardiovascular Research), Stefan Blankenberg(Universität Hamburg), Maja‐Lisa Løchen, Licia Iacoviello(Istituto Neurologico Mediterraneo), V. Salomaa(Finnish Institute for Health and Welfare), Kari Kuulasmaa(Finnish Institute for Health and Welfare), Stephanie Brandt(Universität Hamburg), Stefan Söderberg(Umeå University), Allan Linneberg(Frederiksberg Hospital), Francisco Ojeda, Jan Brederecke(Universität Hamburg), Teemu Niiranen(Edinburgh Napier University), T Zeller(Universität Hamburg)
Cited by 0
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
|European Heart Journal|2024|2.4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k